Endocrine Disease
2
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Neurocrine BiosciencesSAN DIEGO, CA
1 program1
Hydrocortisone Modified Release CapsulesPhase 21 trial
Active Trials
Human BioSciencesWV - Martinsburg
2 programs1
MifepristonePhase 1/21 trial
Evaluation of Women With Endocrine and Reproductive-Related ConditionsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Neurocrine BiosciencesHydrocortisone Modified Release Capsules
Human BioSciencesMifepristone
Human BioSciencesEvaluation of Women With Endocrine and Reproductive-Related Conditions
Clinical Trials (3)
Total enrollment: 868 patients across 3 trials
Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
Start: Dec 2012Est. completion: Dec 201316 patients
Phase 2Completed
Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults
Start: Nov 2011Est. completion: Nov 201519 patients
Phase 1/2Completed
Evaluation of Women With Endocrine and Reproductive-Related Conditions
Start: May 1999Est. completion: May 2023833 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.